Inflammation markers in healthy and periodontitis patients: a preliminary data screening

• Autor(a) principal: Queiroz,Adriana Corrêa de
• Data de Publicação: 2008
• Outros Autores: Taba Jr.,Mario, O'Connell,Patrícia Aquino, Nóbrega,Priscila Brasil da, Costa,Priscila Paganini, Kawata,Viviane Keiko dos Santos, Trevisan,Glauce Lunardelli, Novaes Jr.,Arthur Belém, Souza,Sergio Luís Scombatti de, Palioto,Daniela Bazan, Grisi,Márcio Fernando de Moraes
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Brazilian Dental Journal
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-64402008000100001
• topic: serum; biomarkers; periodontitis

Advances in diagnostic research are moving towards methods whereby the periodontal risk can be identified and quantified by objective measures using biomarkers. Patients with periodontitis may have elevated circulating levels of specific inflammatory markers that can be correlated to the severity of the disease. The purpose of this study was to evaluate whether differences in the serum levels of inflammatory biomarkers are differentially expressed in healthy and periodontitis patients. Twenty-five patients (8 healthy patients and 17 chronic periodontitis patients) were enrolled in the study. A 15 mL blood sample was used for identification of the inflammatory markers, with a human inflammatory flow cytometry multiplex assay. Among 24 assessed cytokines, only 3 (RANTES, MIG and Eotaxin) were statistically different between groups (p<0.05). In conclusion, some of the selected markers of inflammation are differentially expressed in healthy and periodontitis patients. Cytokine profile analysis may be further explored to distinguish the periodontitis patients from the ones free of disease and also to be used as a measure of risk. The present data, however, are limited and larger sample size studies are required to validate the findings of the specific biomarkers.